Abstract
Drug rash with eosinophilia and systemic symptoms syndrome is a severe idiosyncratic drug reaction with a long latency period. It has been described using many terms; however, drug rash with eosinophilia and systemic symptoms syndrome appears to be the most appropriate. This syndrome causes a diverse array of clinical symptoms, anywhere from 2 to 8 weeks after initiating the offending drug. Standardized criteria for the diagnosis have been developed; however, their utility remains to be validated. Unfortunately, the management of drug rash with eosinophilia and systemic symptoms syndrome is not well supported by strong evidence-based data.
Original language | English (US) |
---|---|
Pages (from-to) | 31-37 |
Number of pages | 7 |
Journal | Journal of Clinical and Aesthetic Dermatology |
Volume | 6 |
Issue number | 6 |
State | Published - Jun 1 2013 |
ASJC Scopus subject areas
- Dermatology